Andrew Huberman· PhD
Subcutaneous has slightly longer active half-life, because the esterases take longer to reach that supinate or an estered clavate.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Subcutaneous has slightly longer active half-life, because the esterases take longer to reach that supinate or an estered clavate.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I have seen and I think this is an extrapolation but I believe it to be true is when you look at subq dosing you'll notice the total tea levels are higher and then people take away from that oh subq is like you get more out of your test but the reality is when they measure total test levels it's often a week after your shot so it just lasts longer so I think you are almost giving yourself a sustained release kind of through administering into the fat tissue rather than intramuscular which is more readily absorbed quicker blood flow etc.
if you were I think once you get to every other day dosing it's almost it doesn't almost matter
when you look at subq dosing you'll notice the total T levels are higher and then people take away from that oh subq is like you get more out of your test but the reality is when they measure total test levels it's often a week after your shot just longer so I think you are almost giving yourself a sustained release kind of through administering into the fat tissue rather than intramuscular which is more readily absorbed quicker blood flow Etc